Diagnosis, treatment and outcome of glutaric aciduria type I in Zhejiang Province, China

Medical Science Monitor

Volumn 17, Issue 7, 2011, Pages

  Yang, Lili ^a   Yin, Huaiming ^b   Yang, Rongwang ^a   Huang, Xinwen ^a  

^a ZHEJIANG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b Dept of Neurology   (China)

Author keywords

Diet modifcation; Glutaric aciduria type I; Newborn screening; Outcome

Indexed keywords

CARNITINE; RIBOFLAVIN;

ARTICLE; AUTOSOMAL RECESSIVE DISORDER; CHILD; CHINA; CLINICAL ARTICLE; DIET; DIET SUPPLEMENTATION; FEMALE; GLUTARIC ACIDURIA TYPE 1; HIGH RISK INFANT; HUMAN; INBORN ERROR OF METABOLISM; INFANT; MALE; MASS FRAGMENTOGRAPHY; MENTAL DEFICIENCY; MOTOR RETARDATION; MUSCLE HYPOTONIA; NEUROPHYSIOLOGY; NEWBORN; NEWBORN SCREENING; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOME ASSESSMENT; TANDEM MASS SPECTROMETRY; THERAPY DELAY;

EID: 79960022024     PISSN: 12341010     EISSN: 16433750     Source Type: Journal    
DOI: 10.12659/MSM.881834     Document Type: Article

References (16)

1. Funk CB, Prasad AN, Frosk P et al: Neuropathological, biochemical and molecular fndings in a glutaric acidemia type 1 cohort. Brain, 2005; 128(Pt 4): 711-22
2. Kölker S, Christensen E, Leonard JV et al: Guideline for the diagnosis and management of glutaryl-CoA dehydrogenase defciency (glutaric aciduria type I). J Inherit Metab Dis, 2007; 30: 5-22
3. Lindner M, Kolker S, Schulze A et al: Neonatal screening for glutaryl-CoA dehydrogenase defciency. J Inherit Metab Dis, 2004; 27: 851-59
4. Funk CB, Prasad AN, Frosk P et al: Neuropathological, biochemical and molecular fndings in a glutaric acidemia type 1 cohort. Brain, 2005; 128(Pt 4): 711-22
5. Boneh A, Beauchamp M, Humphrey M et al: Newborn screening for glutaric aciduria type I in Victoria: Treatment and outcome. Mol Genet Metab, 2008; 94: 287-91
6. Bjugstad KB, Goodman SI, Freed CR: Age at symptom onset predicts severity of motor impairment and clinical onset of glutaric aciduria type I. J Pediatr, 2000; 137: 681-86
7. Busquets C, Merinero B, Christensen E et al: Glutaryl-CoA dehydroge-nase defciency in Spain: evidence of two groups of patients, genetically and biochemically distinct. Pediatr Res, 2000; 48: 315-22
8. Hoffmann GF, Athanassopoulos S, Burlina AB et al: Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics, 1996; 27: 115-23
9. Bishop FS, Liu JK, McCall TD, Brockmeyer DL: Glutaric aciduria type 1 presenting as bilateral subdural hematomas mimicking nonacciden-tal trauma. Case report and review of the literature. J Neurosurg, 2007; 106(Suppl.3): 222-26
10. Kölker S, Garbade SF, Greenberg CR et al: Natural history, outcome, and treatment effcacy in children and adults with glutaryl-CoA dehy-drogenase deficiency. Pediatr Res, 2006; 59: 840-47
11. Kolker S, Garbade SF, Boy N et al: Decline of acute encephalopathic crises in children with glutaryl-CoA dehydrogenase deficiency identified by newborn screening in Germany. Pediatr Res, 2007; 62: 357-63
12. Hsieh CT, Hwu WL, Huang YT et al: Early detection of glutaric acid-uria type I by newborn screening in Taiwan. J Formos Med Assoc, 2008; 107: 139-44
13. Monavari AA, Naughten ER: Prevention of cerebral palsy in glutaric aciduria type 1 by dietary management. Arch Dis Child, 2000; 82: 67-70
14. Kyllerman M, Skjeldal O, Christensen E et al: Long-term follow-up, neurological outcome and survival rate in 28 Nordic patients with glutaric aciduria type 1. Eur J Paediatr Neurol, 2004; 8: 121-29
15. Bijarnia S, Wiley V, Carpenter K et al: Glutaric aciduria type I: outcome following detection by newborn screening. J Inherit Metab Dis, 2008; 31: 503-7
16. Heringer J, Boy SP, Ensenauer R et al: Use of guidelines improves the neurological outcome in glutaric aciduria type I. Ann Neurol, 2010; 68: 743-52